TLDR:
- Dallas-based HEST Investments led a $1.8M SPV investment in Baltimore-based Secretome Therapeutics.
- Secretome Therapeutics is developing innovative therapies using naturally occurring molecules that promote healing and regeneration.
Dallas-based venture capital family office HEST Investments announced a successful $1.8 million SPV investment in Baltimore-based Secretome Therapeutics, a biotech company with a presence at BioLabs at Pegasus Park in Dallas. Secretome is at the forefront of developing revolutionary solutions in regenerative medicine by harnessing the power of secretomes, naturally occurring molecules that promote healing and regeneration. HEST’s investment aligns with its focus on innovative ventures that have the potential to make a transformative impact on humanity.
The investment in Secretome will support the company’s progress through human trials, bringing its innovative therapies closer to market. The capital will play a crucial role as Secretome moves its lead asset, STM-01, into two Phase I clinical studies. The collaboration underscores HEST’s commitment to backing companies driving substantial change in fields like life sciences and biotech.
